Women's Health & Hormones

Misoprostol Tablets IP 200 mcg is a synthetic prostaglandin E1 (PGE1) analogue on the WHO Model List of Essential Medicines. It binds to myometrial prostanoid EP receptors, producing strong rhythmic uterine contractions and enzymatic cervical softening/effacement; it also inhibits gastric acid secretion and protects mucosal lining. Indicated for prevention and treatment of postpartum hemorrhage (PPH), cervical ripening and labor induction, medical termination of pregnancy (in combination with mifepristone), and prevention of NSAID-induced peptic ulcers.

Prednisolone (Tablets IP 5mg/10mg/40mg) is an intermediate-acting synthetic glucocorticoid with four times the anti-inflammatory potency of hydrocortisone and minimal mineralocorticoid activity, on the WHO Model List of Essential Medicines. It diffuses across cell membranes and binds intracellular glucocorticoid receptors, inhibiting NF-kB, downregulating phospholipase A2, and potently suppressing synthesis of prostaglandins, leukotrienes, and pro-inflammatory cytokines. Indicated for severe autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis), acute asthma exacerbations, nephrotic syndrome, severe allergic reactions, inflammatory bowel disease, and immunosuppressive therapy.

Prednisolone (Tablets IP 5mg/10mg/40mg) is an intermediate-acting synthetic glucocorticoid with four times the anti-inflammatory potency of hydrocortisone and minimal mineralocorticoid activity, on the WHO Model List of Essential Medicines. It diffuses across cell membranes and binds intracellular glucocorticoid receptors, inhibiting NF-kB, downregulating phospholipase A2, and potently suppressing synthesis of prostaglandins, leukotrienes, and pro-inflammatory cytokines. Indicated for severe autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis), acute asthma exacerbations, nephrotic syndrome, severe allergic reactions, inflammatory bowel disease, and immunosuppressive therapy.

Dexamethasone (Tablets IP 0.5mg) is a long-acting synthetic fluorinated corticosteroid with 25 to 30 times the anti-inflammatory potency of hydrocortisone and virtually no mineralocorticoid (salt-retaining) activity, on the WHO Model List of Essential Medicines. It possesses exceptional tissue penetration including across the blood-brain barrier and placenta. Indicated for cerebral edema (brain tumors, trauma), severe COVID-19 with hypoxemia, croup, antenatal acceleration of fetal lung maturation in threatened preterm birth (24-34 weeks gestation), chemotherapy-induced nausea/vomiting, and severe allergic/anaphylactic crises.

Dexamethasone (Injection IP 4mg/ml) is a long-acting synthetic fluorinated corticosteroid with 25 to 30 times the anti-inflammatory potency of hydrocortisone and virtually no mineralocorticoid (salt-retaining) activity, on the WHO Model List of Essential Medicines. It possesses exceptional tissue penetration including across the blood-brain barrier and placenta. Indicated for cerebral edema (brain tumors, trauma), severe COVID-19 with hypoxemia, croup, antenatal acceleration of fetal lung maturation in threatened preterm birth (24-34 weeks gestation), chemotherapy-induced nausea/vomiting, and severe allergic/anaphylactic crises.

Clomiphene Citrate Tablets IP 50 mg is a non-steroidal selective estrogen receptor modulator (SERM) and first-line ovulatory stimulant on the WHO Model List of Essential Medicines. It antagonizes hypothalamic and pituitary estrogen receptors, blocking negative feedback of endogenous circulating estrogens; this triggers an increase in GnRH pulse frequency and endogenous FSH and LH secretion, stimulating ovarian follicular recruitment and maturation. Indicated for the treatment of ovulatory failure and female anovulatory infertility in women desiring pregnancy, predominantly in polycystic ovary syndrome (PCOS, WHO Group II anovulation).

Mifepristone Tablets IP 200 mg is a synthetic steroid with potent antiprogestational and antiglucocorticoid activity on the WHO Model List of Essential Medicines. It competitively binds with high affinity to intracellular progesterone receptors, disrupting the decidua, detachment of the blastocyst, and cervical softening. Indicated for medical termination of developing intrauterine pregnancy (in combination with prostaglandin), cervical preparation prior to surgical abortion, and induction of labor in intrauterine fetal death.

Doxylamine Succinate and Pyridoxine Hydrochloride Tablets (10mg/10mg, 20mg/20mg) is the first-line evidence-based pharmacotherapy recommended by ACOG and RCOG for nausea and vomiting of pregnancy (NVP / morning sickness) and hyperemesis gravidarum. Doxylamine is an ethanolamine-derivative H1-antihistamine that competitively blocks H1 and muscarinic receptors in the vestibular system and vomiting center; Pyridoxine (Vitamin B6) acts as a coenzyme in neurotransmitter synthesis, improving metabolic pathways disrupted during early pregnancy.

Dydrogesterone Tablets IP 10 mg is an orally active retro-progesterone stereoisomer with highly selective progestogenic activity on the WHO Model List of Essential Medicines. Due to its retro-configuration, it binds selectively to progesterone receptors without significant androgenic, estrogenic, glucocorticoid, or mineralocorticoid activity, providing potent endometrial secretory transformation without inhibiting ovulation or causing metabolic side effects. Indicated for threatened and recurrent miscarriage, luteal phase support in assisted reproductive technologies (ART), endometriosis, dysmenorrhea, irregular menstrual cycles, and dysfunctional uterine bleeding.

Combipack of Mifepristone 200mg (1 Tablet) & Misoprostol 200mcg (4 Tablets) is a sequential antiprogestogenic and prostaglandin regimen approved under the Medical Termination of Pregnancy (MTP) Act for the medical termination of intrauterine pregnancy up to 63 days (9 weeks) of gestation. Mifepristone blocks uterine progesterone receptors, terminating fetal viability and sensitizing the myometrium, followed by Misoprostol which stimulates strong myometrial contractions and cervical dilation to expel gestational products.

Norethisterone (Tablets IP 5mg) is a potent first-generation synthetic 19-nortestosterone-derived progestogen on the WHO Model List of Essential Medicines. It induces profound secretory transformation of the endometrium and inhibits pituitary gonadotropin release, preventing ovulation and stabilizing the uterine vascular bed. Indicated for the treatment of dysfunctional uterine bleeding (DUB / menorrhagia), endometriosis, postponement of menstruation, secondary amenorrhea, and severe premenstrual syndrome (PMS).

Betamethasone (Sodium Phosphate Tablets IP 0.5mg) is a potent, long-acting synthetic glucocorticoid on the WHO Model List of Essential Medicines. Structurally the 16-beta isomer of dexamethasone, it provides potent anti-inflammatory action with zero mineralocorticoid effect and readily crosses the placenta to stimulate fetal type II pneumocyte maturation and surfactant production. Indicated for antenatal prophylaxis of neonatal respiratory distress syndrome (RDS) and intraventricular hemorrhage in preterm labor, severe rheumatoid arthritis, angioedema, and dermatological autoimmune flares.

Prednisolone (Tablets IP 5mg/10mg/40mg) is an intermediate-acting synthetic glucocorticoid with four times the anti-inflammatory potency of hydrocortisone and minimal mineralocorticoid activity, on the WHO Model List of Essential Medicines. It diffuses across cell membranes and binds intracellular glucocorticoid receptors, inhibiting NF-kB, downregulating phospholipase A2, and potently suppressing synthesis of prostaglandins, leukotrienes, and pro-inflammatory cytokines. Indicated for severe autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis), acute asthma exacerbations, nephrotic syndrome, severe allergic reactions, inflammatory bowel disease, and immunosuppressive therapy.

Nandrolone Decanoate Injection IP (25 mg/ml, 50 mg/ml) is a synthetic 19-nortestosterone anabolic-androgenic steroid in an oily depot solution on the WHO Model List of Essential Medicines. It promotes cellular nitrogen retention, stimulates protein synthesis, stimulates renal erythropoietin secretion (enhancing erythropoiesis), and stimulates osteoblastic bone matrix synthesis. Indicated for the adjunctive management of postmenopausal and senile osteoporosis, refractory anemia associated with chronic renal failure, and severe catabolic states / muscle-wasting diseases following extensive trauma or chronic debilitating illness.

Progesterone (Sustained Release Tablets 200mg) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.

Dehydroepiandrosterone (Micronized) 25 mg Capsule is an endogenous steroid prohormone synthesized by the adrenal cortex and ovarian theca cells. As a metabolic precursor to androstenedione, testosterone, and estrone, it plays a critical role in follicular steroidogenesis, enhancing preantral and antral follicle sensitivity to FSH via IGF-1 mediation. Indicated as an adjuvant reproductive therapy for diminished ovarian reserve (DOR), poor ovarian response (POR) in IVF cycles, advanced maternal reproductive age, and age-related hormonal insufficiency.

Betamethasone (Injection IP 4mg/ml) is a potent, long-acting synthetic glucocorticoid on the WHO Model List of Essential Medicines. Structurally the 16-beta isomer of dexamethasone, it provides potent anti-inflammatory action with zero mineralocorticoid effect and readily crosses the placenta to stimulate fetal type II pneumocyte maturation and surfactant production. Indicated for antenatal prophylaxis of neonatal respiratory distress syndrome (RDS) and intraventricular hemorrhage in preterm labor, severe rheumatoid arthritis, angioedema, and dermatological autoimmune flares.

Cabergoline Tablets IP 0.5 mg is a potent, long-acting synthetic ergoline dopamine D2-receptor agonist on the WHO Model List of Essential Medicines. By directly stimulating D2 receptors on anterior pituitary lactotroph cells, it potently suppresses prolactin secretion with a biological half-life of 63 to 69 hours. Indicated for the treatment of hyperprolactinemia (due to idiopathic causes, prolactin-secreting pituitary adenomas/prolactinomas, or empty sella syndrome), inhibition/suppression of physiological postpartum lactation, and prevention of ovarian hyperstimulation syndrome (OHSS) in ART cycles.

Ethinylestradiol and Levonorgestrel Tablets IP is a second-generation low-dose Combined Oral Contraceptive (COC) pill on the WHO Model List of Essential Medicines. It synergistically suppresses the mid-cycle LH surge to inhibit ovulation, renders cervical mucus hostile to sperm migration, and alters the endometrium. Second-generation levonorgestrel combinations demonstrate the lowest epidemiological relative risk of venous thromboembolism among combined oral contraceptives. Indicated for prevention of pregnancy, cycle regulation, and treatment of dysmenorrhea.

Human Chorionic Gonadotrophin (hCG) IP 5000 IU (Powder for injection with solvent) is a purified polypeptide gonadotropic hormone obtained from the urine of pregnant women. It acts as an LH surrogate by binding to the LH/CG receptor on granulosa and theca cells, triggering final oocyte maturation, follicular rupture (ovulation), and luteinization of the ruptured follicle with sustained progesterone production. Indicated for ovulation induction and luteal phase support in anovulatory infertility/assisted reproduction (IVF/IUI), and for prepubertal cryptorchidism and hypogonadotropic hypogonadism in males.

Hydrocortisone (Sodium Succinate Injection IP 100mg) is the bioidentical synthetic equivalent of endogenous human cortisol on the WHO Model List of Essential Medicines. It possesses balanced 1:1 glucocorticoid and mineralocorticoid activity, providing vital metabolic regulation, vascular tone maintenance, and immune stabilization. Indicated for acute adrenal crisis / Addisonian crisis (emergency IV therapy), chronic primary or secondary adrenocortical insufficiency (oral physiological replacement), congenital adrenal hyperplasia (CAH), severe septic shock unresponsive to vasopressors, and life-threatening anaphylaxis.

Medroxyprogesterone Acetate Tablets IP 10 mg is a synthetic derivative of 17-alpha-hydroxyprogesterone on the WHO Model List of Essential Medicines. It binds to progesterone receptors to transform proliferative endometrium into secretory tissue, reduces endometrial hyperplasia in estrogen replacement regimens, and inhibits gonadotropin production. Indicated for secondary amenorrhea, abnormal uterine bleeding due to hormonal imbalance without organic pathology, endometriosis, and endometrial protection during menopausal estrogen therapy.

Progesterone (Natural Micronised Capsules 100mg/200mg) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.

Progesterone (Natural Micronised Capsules 100mg/200mg) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.

Doxylamine Succinate and Pyridoxine Hydrochloride Tablets (10mg/10mg, 20mg/20mg) is the first-line evidence-based pharmacotherapy recommended by ACOG and RCOG for nausea and vomiting of pregnancy (NVP / morning sickness) and hyperemesis gravidarum. Doxylamine is an ethanolamine-derivative H1-antihistamine that competitively blocks H1 and muscarinic receptors in the vestibular system and vomiting center; Pyridoxine (Vitamin B6) acts as a coenzyme in neurotransmitter synthesis, improving metabolic pathways disrupted during early pregnancy.

Nandrolone Decanoate Injection IP (25 mg/ml, 50 mg/ml) is a synthetic 19-nortestosterone anabolic-androgenic steroid in an oily depot solution on the WHO Model List of Essential Medicines. It promotes cellular nitrogen retention, stimulates protein synthesis, stimulates renal erythropoietin secretion (enhancing erythropoiesis), and stimulates osteoblastic bone matrix synthesis. Indicated for the adjunctive management of postmenopausal and senile osteoporosis, refractory anemia associated with chronic renal failure, and severe catabolic states / muscle-wasting diseases following extensive trauma or chronic debilitating illness.

Triamcinolone (Acetonide Injection IP 40mg/ml) is an intermediate-acting synthetic fluorinated corticosteroid with 5 times the anti-inflammatory potency of hydrocortisone and no mineralocorticoid activity, on the WHO Model List of Essential Medicines. Formulated as a microcrystalline suspension for depot injection, it provides sustained local anti-inflammatory effect over 3 to 6 weeks. Indicated for intra-articular injection in severe osteoarthritis/rheumatoid arthritis, intralesional injection in keloids/alopecia areata, deep IM systemic therapy for chronic severe allergic conditions, and oral therapy for inflammatory disorders.

Triamcinolone (Tablets IP 4mg) is an intermediate-acting synthetic fluorinated corticosteroid with 5 times the anti-inflammatory potency of hydrocortisone and no mineralocorticoid activity, on the WHO Model List of Essential Medicines. Formulated as a microcrystalline suspension for depot injection, it provides sustained local anti-inflammatory effect over 3 to 6 weeks. Indicated for intra-articular injection in severe osteoarthritis/rheumatoid arthritis, intralesional injection in keloids/alopecia areata, deep IM systemic therapy for chronic severe allergic conditions, and oral therapy for inflammatory disorders.

Allylestrenol Tablets 5 mg is a synthetic oral progestogen derivative of 19-nortestosterone designed specifically for obstetric support. It stimulates placental trophoblast activity, enhances endogenous placental progesterone and human chorionic gonadotrophin (hCG) synthesis, normalizes oxytocinase levels, and suppresses myometrial hypercontractility without exerting androgenic or estrogenic virilizing effects on the female fetus. Indicated for threatened miscarriage, habitual abortion, threatened preterm labor, and intrauterine growth restriction (IUGR) due to placental insufficiency.

Ethinylestradiol 0.03 mg and Desogestrel 0.15 mg Tablets is a third-generation low-dose monophasic Combined Oral Contraceptive (COC) pill on the WHO Model List of Essential Medicines. It prevents pregnancy primarily by suppressing pituitary gonadotropin secretion (inhibiting ovulation), thickening cervical mucus to prevent sperm penetration, and altering the endometrium to impair implantation. Desogestrel has high progestogenic potency and low androgenic activity, causing less acne and weight gain than older progestogens.

Ethinylestradiol and Levonorgestrel Tablets IP is a second-generation low-dose Combined Oral Contraceptive (COC) pill on the WHO Model List of Essential Medicines. It synergistically suppresses the mid-cycle LH surge to inhibit ovulation, renders cervical mucus hostile to sperm migration, and alters the endometrium. Second-generation levonorgestrel combinations demonstrate the lowest epidemiological relative risk of venous thromboembolism among combined oral contraceptives. Indicated for prevention of pregnancy, cycle regulation, and treatment of dysmenorrhea.

Isoxsuprine Injection IP 5 mg is a beta-2 adrenergic receptor agonist and direct vascular/uterine smooth muscle relaxant. By stimulating beta-2 adrenoreceptors in the myometrium, it activates adenylate cyclase and increases intracellular cAMP, decreasing intracellular calcium and producing profound relaxation of uterine smooth muscle (tocolysis); it also produces peripheral vasodilation. Indicated for the management of threatened abortion, threatened uncomplicated premature labor (tocolytic therapy between 20-36 weeks gestation), and peripheral vascular diseases (Raynaud's phenomenon, arteriosclerosis obliterans).

Prednisolone (Tablets IP 5mg/10mg/40mg) is an intermediate-acting synthetic glucocorticoid with four times the anti-inflammatory potency of hydrocortisone and minimal mineralocorticoid activity, on the WHO Model List of Essential Medicines. It diffuses across cell membranes and binds intracellular glucocorticoid receptors, inhibiting NF-kB, downregulating phospholipase A2, and potently suppressing synthesis of prostaglandins, leukotrienes, and pro-inflammatory cytokines. Indicated for severe autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis), acute asthma exacerbations, nephrotic syndrome, severe allergic reactions, inflammatory bowel disease, and immunosuppressive therapy.

Valethamate Bromide Injection 8 mg/ml is a synthetic anticholinergic quaternary ammonium compound with combined antimuscarinic and direct musculotropic antispasmodic properties. It selectively blocks muscarinic receptors on the cervix and lowers cervical smooth muscle tone, facilitating rapid cervical softening, effacement, and dilatation without impairing physiological fundal myometrial contractions. Indicated for acceleration of cervical dilatation in the active phase of labor, management of cervical dystocia, and visceral spasms (spasmodic dysmenorrhea, biliary/renal colic).

Anti-D (Rho) Immunoglobulin (Monoclonal) 300 mcg is a sterile preparation of specific human IgG antibodies against the Rh(D) antigen on red blood cells, produced using recombinant or human monoclonal technology, on the WHO Model List of Essential Medicines. It binds to and neutralizes circulating fetal Rh(D)-positive erythrocytes in the maternal bloodstream before maternal immune recognition occurs, preventing maternal B-cell sensitization and Rh isoimmunization. Indicated for the prevention of hemolytic disease of the newborn (HDN) in Rh-negative mothers pregnant with an Rh-positive infant, routine antenatal prophylaxis at 28 weeks gestation, postpartum administration within 72 hours of delivery, and following miscarriages, ectopic pregnancies, amniocentesis, or abdominal trauma.

Carboprost Tromethamine Injection 125 mcg is a synthetic 15-methyl analogue of Prostaglandin F2-alpha (PGF2a). It produces sustained, intense myometrial contractions and local vasoconstriction to achieve mechanical hemostasis at the placental bed. Indicated for the control and refractory treatment of severe postpartum hemorrhage (PPH) due to uterine atony that has failed to respond to oxytocin, methylergometrine, or uterine massage, and for mid-trimester abortion.

Dinoprostone Gel 0.5 mg (Pre-filled syringe) is a sterile endocervical gel containing synthetic Prostaglandin E2 (PGE2) on the WHO Model List of Essential Medicines. It stimulates local collagenase breakdown, cervical ripening, dilatation, and myometrial contractility mimicking natural onset of labor. Indicated for cervical ripening and induction of labor in pregnant women at or near term with a medical or obstetric indication for induction and an unfavorable Bishop's score (<=6).

Ethinylestradiol 0.035 mg and Cyproterone Acetate 2 mg Tablet is a combined hormonal formulation containing an estrogen and a potent anti-androgenic progestogen. Cyproterone competitively blocks androgen receptors and suppresses ovarian androgen synthesis, while Ethinylestradiol increases Sex Hormone-Binding Globulin (SHBG) synthesis, drastically reducing free circulating testosterone. Indicated for the treatment of severe androgen-dependent acne (with or without seborrhea), moderate to severe hirsutism, and polycystic ovary syndrome (PCOS) in women of reproductive age requiring oral contraception.

Ulipristal Acetate Tablets 5 mg is an orally active, synthetic Selective Progesterone Receptor Modulator (SPRM). It exerts tissue-specific partial agonistic and antagonistic effects on human progesterone receptors, directly suppressing endometrial proliferation, inducing amenorrhea, inhibiting ovulation, and promoting apoptosis in uterine leiomyoma cells, resulting in rapid reduction of uterine fibroid size and heavy menstrual bleeding. Indicated for pre-operative and intermittent medical management of moderate to severe symptoms of uterine fibroids (leiomyomas) in adult women of reproductive age.

Levonorgestrel Tablet IP 1.5 mg is a synthetic second-generation progestogen emergency contraceptive on the WHO Model List of Essential Medicines. When administered during the pre-ovulatory phase, it prevents or delays the LH surge and subsequent follicular rupture/ovulation; it also impairs sperm motility and thickens cervical mucus. Indicated as an emergency post-coital contraceptive within 72 hours (3 days) of unprotected sexual intercourse or known contraceptive failure (e.g. condom breakage, missed pills). It is NOT an abortifacient and will not terminate an established pregnancy.

Prednisolone (Tablets IP 5mg/10mg/40mg) is an intermediate-acting synthetic glucocorticoid with four times the anti-inflammatory potency of hydrocortisone and minimal mineralocorticoid activity, on the WHO Model List of Essential Medicines. It diffuses across cell membranes and binds intracellular glucocorticoid receptors, inhibiting NF-kB, downregulating phospholipase A2, and potently suppressing synthesis of prostaglandins, leukotrienes, and pro-inflammatory cytokines. Indicated for severe autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis), acute asthma exacerbations, nephrotic syndrome, severe allergic reactions, inflammatory bowel disease, and immunosuppressive therapy.

Estradiol Tablets 2 mg is a bioidentical 17-beta-estradiol formulation identical to endogenous human ovarian estradiol. It restores estrogen receptor activation in the brain, bone, urogenital tract, and cardiovascular system. Indicated for the relief of menopausal symptoms (hot flushes, night sweats, sleep disturbances), management of hypoestrogenism (oophorectomy, primary ovarian insufficiency), endometrial priming in assisted reproduction (frozen embryo transfer / donor egg IVF cycles), and prevention of postmenopausal bone loss.

Progesterone (Injection IP 100mg/2ml) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.

Hydroxyprogesterone Caproate Injection IP (250mg, 500mg) is a long-acting synthetic esterified progestogen formulated in an oily depot solution. It binds to uterine progesterone receptors, producing prolonged quietening of the myometrium, inhibiting cervical shortening, and suppressing inflammatory cytokine-mediated uterine contractility. Indicated for the prevention of recurrent preterm birth in pregnant women with a singleton pregnancy and a documented history of spontaneous preterm singleton delivery, habitual/threatened miscarriage, and uterine bleeding disorders.

Hydroxyprogesterone Caproate Injection IP (250mg, 500mg) is a long-acting synthetic esterified progestogen formulated in an oily depot solution. It binds to uterine progesterone receptors, producing prolonged quietening of the myometrium, inhibiting cervical shortening, and suppressing inflammatory cytokine-mediated uterine contractility. Indicated for the prevention of recurrent preterm birth in pregnant women with a singleton pregnancy and a documented history of spontaneous preterm singleton delivery, habitual/threatened miscarriage, and uterine bleeding disorders.

Somatotropin 4 IU (Recombinant Human Growth Hormone - rhGH) Powder for Injection is a biosynthetic 191-amino acid polypeptide hormone produced via recombinant DNA technology, identical to human pituitary growth hormone, on the WHO Model List of Essential Medicines. It stimulates hepatic production of Insulin-like Growth Factor-1 (IGF-1), stimulating chondrocyte proliferation, longitudinal linear skeletal growth in children with open epiphyses, skeletal muscle hypertrophy, lipolysis, and protein synthesis. Indicated for growth hormone deficiency (GHD) in children and adults, Turner syndrome, Prader-Willi syndrome, chronic kidney disease-induced growth failure, and small-for-gestational-age (SGA) children failing to catch up by age 2-4 years.

Lactic Acid 1.2% w/v Intimate Hygiene Wash is a dermatologically tested, soap-free topical wash enriched with natural lactic acid, tea tree oil, and sea buckthorn oil. It is scientifically formulated to preserve and maintain the optimal physiological acidic microenvironment (pH 3.5 to 4.5) of the female external vulvar area, supporting beneficial Lactobacillus flora and preventing the overgrowth of pathogenic bacteria and fungi responsible for bacterial vaginosis and candidiasis. Indicated for daily feminine external hygiene, during menstruation, post-partum recovery, and post-intimacy cleansing.

Conjugated Estrogens 0.625 mg Tablets is a mixture of natural estrogenic substances (principally sodium estrone sulfate and sodium equilin sulfate) on the WHO Model List of Essential Medicines. It binds to nuclear estrogen receptors (ER-alpha and ER-beta), activating gene transcription to replenish declining endogenous estrogen levels in postmenopausal women. Indicated for the management of moderate to severe vasomotor symptoms (hot flashes, night sweats) and vulvovaginal atrophy associated with menopause, and prevention of postmenopausal osteoporosis.

Deflazacort Oral Suspension 6 mg per 5 ml is an oxazoline derivative of prednisolone with high glucocorticoid and minimal mineralocorticoid activity. In comparative clinical trials, it exhibits a more favorable metabolic and bone safety profile, causing significantly less calcium loss, bone demineralization, growth retardation, and carbohydrate intolerance than conventional prednisone or prednisolone. Indicated for Duchenne muscular dystrophy (DMD) in pediatric patients (age >=2 years), juvenile idiopathic arthritis, severe pediatric asthma, nephrotic syndrome, and chronic autoimmune disorders.

Norethisterone (Acetate Controlled Release Tablets 10mg) is a potent first-generation synthetic 19-nortestosterone-derived progestogen on the WHO Model List of Essential Medicines. It induces profound secretory transformation of the endometrium and inhibits pituitary gonadotropin release, preventing ovulation and stabilizing the uterine vascular bed. Indicated for the treatment of dysfunctional uterine bleeding (DUB / menorrhagia), endometriosis, postponement of menstruation, secondary amenorrhea, and severe premenstrual syndrome (PMS).

Hydrocortisone (Tablets 5mg/10mg) is the bioidentical synthetic equivalent of endogenous human cortisol on the WHO Model List of Essential Medicines. It possesses balanced 1:1 glucocorticoid and mineralocorticoid activity, providing vital metabolic regulation, vascular tone maintenance, and immune stabilization. Indicated for acute adrenal crisis / Addisonian crisis (emergency IV therapy), chronic primary or secondary adrenocortical insufficiency (oral physiological replacement), congenital adrenal hyperplasia (CAH), severe septic shock unresponsive to vasopressors, and life-threatening anaphylaxis.

Hydrocortisone (Tablets 5mg/10mg) is the bioidentical synthetic equivalent of endogenous human cortisol on the WHO Model List of Essential Medicines. It possesses balanced 1:1 glucocorticoid and mineralocorticoid activity, providing vital metabolic regulation, vascular tone maintenance, and immune stabilization. Indicated for acute adrenal crisis / Addisonian crisis (emergency IV therapy), chronic primary or secondary adrenocortical insufficiency (oral physiological replacement), congenital adrenal hyperplasia (CAH), severe septic shock unresponsive to vasopressors, and life-threatening anaphylaxis.

Carbetocin Injection 100 mcg/ml is a synthetic, long-acting nonapeptide analogue of human oxytocin on the WHO Model List of Essential Medicines. It possesses structural modifications that provide resistance to enzymatic degradation, conferring a half-life of ~40 minutes (4 to 10 times longer than oxytocin) and generating continuous rhythmic uterine contractions for several hours. Indicated for the prevention of postpartum hemorrhage (PPH) due to uterine atony following vaginal birth or cesarean delivery under epidural or spinal anesthesia.

Testosterone Enanthate Injection 250 mg/ml is a long-acting esterified androgen in a sterile sesame/castor oil depot vehicle on the WHO Model List of Essential Medicines. Cleaved slowly by serum esterases, it releases bioidentical testosterone which binds to androgen receptors, restoring normal male physiological testosterone levels, promoting secondary sexual characteristics, nitrogen retention, bone mineralization, erythropoiesis, and libido. Indicated for male hypogonadism (primary testicular failure or hypogonadotropic hypogonadism), delayed puberty in adolescent males, and female-to-male (transmasculine) gender-affirming hormone therapy.

Prednisolone (Syrup 15mg/5ml) is an intermediate-acting synthetic glucocorticoid with four times the anti-inflammatory potency of hydrocortisone and minimal mineralocorticoid activity, on the WHO Model List of Essential Medicines. It diffuses across cell membranes and binds intracellular glucocorticoid receptors, inhibiting NF-kB, downregulating phospholipase A2, and potently suppressing synthesis of prostaglandins, leukotrienes, and pro-inflammatory cytokines. Indicated for severe autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis), acute asthma exacerbations, nephrotic syndrome, severe allergic reactions, inflammatory bowel disease, and immunosuppressive therapy.

Prednisolone (Dispersible Tablets 20mg) is an intermediate-acting synthetic glucocorticoid with four times the anti-inflammatory potency of hydrocortisone and minimal mineralocorticoid activity, on the WHO Model List of Essential Medicines. It diffuses across cell membranes and binds intracellular glucocorticoid receptors, inhibiting NF-kB, downregulating phospholipase A2, and potently suppressing synthesis of prostaglandins, leukotrienes, and pro-inflammatory cytokines. Indicated for severe autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis), acute asthma exacerbations, nephrotic syndrome, severe allergic reactions, inflammatory bowel disease, and immunosuppressive therapy.

Prednisolone (Tablets IP 5mg/10mg/40mg) is an intermediate-acting synthetic glucocorticoid with four times the anti-inflammatory potency of hydrocortisone and minimal mineralocorticoid activity, on the WHO Model List of Essential Medicines. It diffuses across cell membranes and binds intracellular glucocorticoid receptors, inhibiting NF-kB, downregulating phospholipase A2, and potently suppressing synthesis of prostaglandins, leukotrienes, and pro-inflammatory cytokines. Indicated for severe autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis), acute asthma exacerbations, nephrotic syndrome, severe allergic reactions, inflammatory bowel disease, and immunosuppressive therapy.